Sotera Health US logo

Sotera Health US

Stock
Stock
Ticker: SHC
SHC

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Sotera Health US is $5.15B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Sotera Health US is 31.76. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Sotera Health US's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.569. EPS indicates the company's profitability on a per-share basis.
Currently, 11 analysts cover Sotera Health US's stock, with a consensus target price of $22.72. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Sotera Health US reported a revenue of $1.22B.
Sotera Health US's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $576.16M. EBITDA measures the company's overall financial performance.
Sotera Health US has a free cash flow of $109.78M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Sotera Health US employs approximately 3,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Sotera Health US is 279.37M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$5.15B
EPS (TTM) 
$0.569
Free Float 
279.37M
P/E ratio (TTM) 
31.76
Revenue (TTM) 
$1.22B
EBITDA (TTM) 
$576.16M
Free Cashflow (TTM) 
$109.78M

Pricing

1D span
$17.75$18.15
52W span
$13.10$19.84

Analyst Ratings

The price target is $22.72 and the stock is covered by 11 analysts.

Buy

9

Hold

2

Sell

0

Information

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. It also provides end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers. The firm operates through the following businesses: Sterigenics, Nordion, and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets by using following technologies: gamma irradiation, EO processing and E-beam irradiation. The Nordion business provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. The Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was founded in 1978 and is headquartered in Broadview Heights, OH.

Employees
3,000
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
SHC

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation